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Summary
WAP-8294A is a group of cyclic lipodepsipeptides
and considered as the first-in-class new chemical
entity with potent activity against methicillin-resis-
tant Staphylococcus aureus. One of the roadblocks
in developing the WAP-8294A antibiotics is the very
low yield in Lysobacter. Here, we carried out a sys-
tematic investigation of the nutritional and environ-
mental conditions in an engineered L. enzymogenes
strain for the optimal production of WAP-8294A. We
developed an activity-based simple method for quick
screening of various factors, which enabled us to
optimize the culture conditions. With the method, we
were able to improve the WAP-8294A yield by 10-fold
in small-scale cultures and approximately 15-fold in
scale-up fermentation. Additionally, we found the
ratio of WAP-8294A2 to WAP-8294A1 in the strains
could be manipulated through medium optimization.
The development of a practical method for yield
improvement in Lysobacter will facilitate the ongoing
basic research and clinical studies to develop WAP-
8294A into true therapeutics.
Introduction
The constant emergence of multidrug-resistant bacterial
pathogens is a major threat to human health, and noso-
comial infections caused by methicillin-resistant Staphy-
lococcus aureus (MRSA) in hospitals have become an
especially serious clinical problem. Vancomycin serves
as the cornerstone of the treatment of these drug-resis-
tant Gram-positive infections in the past several dec-
ades, which is regarded as a last resort in treating
MRSA infections. Unfortunately, there are significant
concerns owing to decreasing susceptibility to this agent
among S. aureus, and clinical failures in treatment of
bacteremia and endocarditis. In the past decade, several
new drugs, such as daptomycin, telavancin and ceftaro-
line, have been approved for the treatment of infections
caused by drug-resistant Gram-positive pathogens
(Choo and Chambers, 2016). However, the occurrence
of drug resistance to these antibiotics is not a question
of if but when, and there have been reports on MRSA
resistant to daptomycin and telavancin (Nigo et al.,
2017; Roch et al., 2017). Therefore, the discovery of
new antibiotics is an urgent and continual need for
human health.
WAP-8294A is a family of cyclic lipodepsipeptides
containing a 40-membered macrocycle comprising 12
amino acid residues linked by a small hydroxylated fatty
acid. The members of family share the same peptide
scaffold and differ by the fatty acid (Fig. 1) (Kato et al.,
1997, 1998, 2011; Itoh et al., 2018). For example, WAP-
8294A2 (Lotilibcin) contains (R)-3-hydroxy-7-methyloc-
tanoic acid and is 14 times more active than vancomycin
in anti-MRSA activity (median effective dose [ED50] of
0.38 mg kg1 for WAP-8294A2 and 5.3 mg kg1 for
vancomycin). WAP-8294A2 is considered the first-in-
class new chemical entity (depsipeptides) with a high
promise for the development of new antibiotics against
multidrug-resistant human pathogenic bacteria. It has
been in clinical trials by several biotech companies (Pirri
et al., 2009). The WAP-8294A compounds were origi-
nally isolated from the environmental Gram-negative
bacterium Lysobacter staphylocidin, and WAP-8294A1,
WAP-8294A2 and WAP-8294A4 are the main products
(Fig. 1) (Kato et al., 1997). Later, our group identified the
WAP-8294A biosynthetic gene cluster from L. enzymo-
genes OH11 (Zhang et al., 2011). The cluster contains
two large nonribosomal peptide synthetase (NRPS)
genes that encode a total of 12 modules responsible for
the assembly of the 12 amino acids core structure of
WAP-8294A compounds (Zhang et al., 2011). In addi-
tion, we found several acyl-CoA ligase genes are
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involved in the fatty acyl activation and incorporation in
WAP-8294A2 biosynthesis (Chen et al., 2015).
While WAP-8294A2 is a very promising new antibiotic,
the drug development has been slow. One of the road-
blocks is the very low yield of the WAP-8294A
compounds, which are produced by Lysobacter only
under certain conditions (Zhang et al., 2011). It is vital to
develop new methods for yield improvement in Lysobac-
ter, so that both the basic research (such as struc-
tureactivity relationship and mode of action) and
(A)
(B) (C)
Fig. 1. Chemical structure of the main WAP-8294A compounds isolated from Lysobacter enzymogenes OH11 (A), total ion current of extracts
from the wild-type OH11 growing in the starting GSS medium and the optimized GBS medium (B), and mass spectrometry of WAP-8294A1, A2
and A4 (C).
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clinical studies can be pushed forward. A sophisticate
chemical total synthesis has been reported for WAP-
8294A2, which took more than 30 synthetic steps with a
4% overall yield (Itoh et al., 2018). The chemical synthe-
sis of WAP-8294A2 for the drug development is not fea-
sible at this stage due to the very complex structure.
The biological synthesis through fermentation of engi-
neered Lysobacter strains under optimized growth condi-
tions remains a feasible approach. Previously, we have
tested two biological methods for improving WAP-8294A
production in L. enzymogenes OH11. The first was
through increasing the expression of a regulator gene in
the WAP gene cluster (Wang et al., 2013). A TonB-de-
pendent receptor gene (orf8) was put under the control
of a constitutive promoter, PHSAF, and the resultant
L. enzymogenes strain gave a twofold higher yield of
WAP-8294A2 than the wild strain. The second strategy
was the combined use of CRISPR/dCas9-mediated gene
(orf15) expression and refactoring of self-protection
gene (orf6, orf 7, orf 9 and orf10) (Yu et al., 2018). This
led to an enhanced production of WAP-8294A by four-
to ninefold in the engineered strains over the starting
strain. Although both strategies increased the WAP-
8294A production in L. enzymogenes OH11, they
require strict culture conditions to maintain the genetic
modifications. A more practical method is needed in
order to achieve a realistic and satisfactory production of
the antibiotics.
The pathway for WAP-8294A biosynthesis in L. enzy-
mogenes OH11 is highly complex. The chemical struc-
ture of all WAP-8294A is built from 12 amino acids and
a (R)-3-hydroxy fatty acid (Fig. 1). The WAP biosyn-
thetic gene cluster contains at least 10 genes, and the
scaffold of WAP-8294A is biosynthesized by a complex
of 48 domains within the 12 modules of NRPS (Zhang
et al., 2011). If any of 12 precursor amino acids is short
in supply, the final WAP-8294A production would be
affected. Moreover, because the limiting factors in
WAP-8294A biosynthesis are not well understood at
present, a global strategy for bioprocess optimization
could probably provide a better chance for further
improving WAP-8294A production. In addition, the 12
precursor amino acids of WAP-8294A are shared by
many metabolite pathways in L. enzymogenes; weaken-
ing or deletion of these competition pathways could
benefit WAP-8294A production in theory. In this study,
we carried out a systematic investigation of nutritional
and environmental conditions in an engineered L. enzy-
mogenes strain (OH11-MHSAF, in which the key
biosynthetic gene for the main metabolite HSAF in
L. enzymogenes has been deleted) for optimal produc-
tion of WAP-8294A. Additionally, we found the ratio of
WAP-8294A2 to WAP-8294A1 in the strains could be
manipulated through medium optimization.
Results
WAP-8294A production in L enzymogenes
The WAP-8294A family consists of more than a dozen
of congeners, with WAP-8294A1, A2 and A4 being the
main compounds produced by Lysobacter (Fig 1A)
(Zhang et al., 2011; Yu et al., 2018). To perform the
yield improvement studies, we need to verify the WAP-
8294A production in the strains. The HPLC analysis of
the crude extract from OH11 showed three main peaks,
coincident with the standard WAP-8294A1, A2 and A4
respectively (Fig 1B). The compounds were further con-
firmed by mass spectrometry, which gave the expected
mass for both [M+H]+ ion and [M + 2H]2+ ion for each of
the three main congeners of the WAP family (Fig 1C).
Semi-quantitative determination of WAP-8294A titre
using critical dilution assay of inhibition zone
GSS had been the most commonly used medium for WAP-
8294A production (Kato et al., 1997; Zhang et al., 2011;
Yu et al., 2018). However, the yield of WAP-8294A in the
cultures of OH11 strains was very low for a direct quantifi-
cation by HPLC. It is necessary to develop a relatively fast
and reliable method to quantify the amount of WAP-8294A,
before the optimization of the media and growth conditions
of the various producing strains. Because WAP-8294A
compounds have a strong antimicrobial activity against
Bacillus subtilis, we figure a semi-quantitative method for
WAP-8294A could be developed based on inhibition zone
assay for a serial diluted fermentation broth. The fermenta-
tion broth of L. enzymogenes strain OH11 growing in GSS
exhibited a clear inhibition zone, while the mutant with the
WAP-8294A biosynthetic gene deleted, L. enzymogenes
OH11-MWAP (Wang et al., 2014), did not produce an inhi-
bition zone (Fig 2A). This confirmed that the inhibition zone
was formed mainly due to WAP-8294A production. In addi-
tion, the supernatant of strain OH11 produced inhibition
zones with different diameters by serial dilution assay
(Fig 2B). In parallel, vancomycin also formed inhibition
zones with different diameters by serial dilution assay. The
relationship between vancomycin concentration and inhibi-
tion zone diameter formed an exponential equation with a
R2 of 0.999, indicating that the equation could explain the
relationship with 99.9% reliability (Fig 2C). We conse-
quently used ‘vancomycin equivalent’ to semi-quantita-
tively estimate the WAP-8294A concentration in
fermentation broth.
WAP-8294A production in strains OH11 and OH11-M
HSAF
Using the semi-quantitative method, we estimated the
WAP-8294A production in the OH11 strains. We used
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three media, GSS, 10% TSB and R2A, for Lysobacter
fermentation and compared the total yield of WAP-
8294A, culture density (OD600 nm) and the relative yield
(WAP/OD600 nm) between the strains (Fig 3). The WAP-
8294A yield in GSS medium was 3~6 times higher than
that in 10% TSB and R2A media. Strain OH11-MHSAF
reached the highest WAP-8294A yield of 126.78 lg van-
comycin equivalent per ml in GSS medium (Fig 3A). In
addition, GSS medium gave the highest cell density
(Fig 3B), but resulting in a low relative yield (Fig 3C).
The other two media gave a higher relative yield than
GSS, but they produced a significantly lower total yield
than GSS. In GSS medium, the time-courses indicated
that the strains grew in a similar density in the 72-h
course and strain OH11-MHSAF gave a higher yield than
strain OH11 (Fig. S1). Since the goal of this study was
to improve the total yield of WAP-8294A compounds, we
chose OH11-MHSAF as the starting strain and GSS
medium as the starting medium for yield optimization in
the subsequent experiments.
Optimization of media and growth conditions for WAP-
8294A production
The effects of monosaccharides (glucose and galac-
tose), disaccharides (lactose, maltose and sucrose),
polysaccharides (dextrin and starch) and polyols (glyc-
erol and sorbitol) on WAP-8294A production and cell
growth were evaluated at the concentration of 20 g l1.
The results showed that disaccharides were favourite
carbon sources for WAP-8294A production and cell
growth by strain OH11-MHSAF, while polyols were dis-
favoured by this strain (Fig. 4A–C). Interestingly, this
strain could utilize polysaccharides for cell growth and
WAP-8294A production. As shown in Fig. 4A, glucose,
lactose, maltose, sucrose and dextrin gave the highest
level of WAP-8294A production, in the range of 130–
155 lg vancomycin equivalent per ml. In contrast, galac-
tose gave the lowest WAP-8294A production, which was
even lower than the control (without a carbon source).
Moreover, glucose, maltose and sucrose sustained the
highest cell growth, OD600 nm ~13 (Fig. 4B). For the rela-
tive yield, glucose, lactose, maltose, sucrose and dextrin
exhibited a higher WAP/OD600 nm than other carbon
sources. Among them, lactose achieved the highest rela-
tive yield (Fig. 4C). Glucose also achieved a high WAP-
8294A yield, a high cell growth and a high relative yield
among the 9 carbon sources (Fig. 4A–C). Considering
glucose is a common carbon source used in fermenta-
tion industry, we chose glucose as the optimal carbon
source in the modified medium (GBS) for WAP-8294A
production in strain OH11-MHSAF.
To screen for an optimal nitrogen source for WAP-
8294A production, we tested nine organic nitrogen
sources (beef extract, casein acid, tryptone, peptone,
soybean flour, malt extract, corn steep liquor, yeast
extract and urea) and three inorganic nitrogen sources
(NH4Cl, (NH4)2SO4 and Na2NO3) at the concentrations
Fig. 2. Semi-quantitative measurement of WAP-8294A from Lysobacter enzymogenes OH11, using the size of inhibition zones of the indicator
microorganism Bacillus subtilis. A. Inhibitory activity of fermentation broth from (3) the wild-type strain OH11 (10 ll) and (4) the WAP deletion
mutant OH11-MWAP (10 ll) of L. enzymogenes growing in GSS medium, with (1) blank medium (10 ll) and (2) gentamicin (10 ll, 50 lg ml1)
as control.B. Inhibition zones of B. subtilis on solid LB medium by WAP-8294A preparations from OH11 (WT) grown in GSS, 10% TSB or R2A
media, at 30°C for 72 h, with serial dilutions of vancomycin (starting concentration 50 lg ml1) as control.C. A standard curve of vancomycin
concentrations versus inhibition zone diameters on solid LB medium and the derived equation, where X is the inhibition zone diameter, and Y is
the concentration of vancomycin. The data were obtained from five repeated experiments.
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of 5, 10 and 20 g l1 (Fig. 4D–F). Strain OH11-MHSAF
barely grew in GSS medium without a nitrogen source
and did not produce any WAP-8294A (data not shown).
All the investigated nitrogen sources, except soybean
flour, achieved the highest WAP-8294A yield when the
concentration of the nitrogen source was at 5 g l1; a
higher concentration actually gave a lower yield
(Fig. 4D). Overall, 5 g l1 beef extract, 5 g l1 yeast
extract, 5 g l1 tryptone and 20 g l1 soybean flour gave
the highest WAP-8294A production of 233.8, 197.6,
133.7 and 117.1 lg vancomycin equivalent per ml
respectively. Among the inorganic nitrogen sources,
(NH4)2SO4 achieved the highest WAP-8294A yield of
32.5 lg vancomycin equivalent per ml. These results
indicated that nitrogen source plays a crucial role in
WAP-8294A production, and the WAP-8294A yield
depends on the nitrogen source’s type and concentra-
tion. As for cell growth, the organic nitrogen sources (ex-
cept for urea) were significantly better than the inorganic
nitrogen sources (Fig. 4E). OD600 nm of 14.85, 14.71,
13.93 and 9.68 was obtained from the medium contain-
ing 10 g l1 yeast extract, 20 g l1 corn steep liquor,
10 g l1 soybean flour and 10 g l1 beef extract respec-
tively. However, the highest WAP/OD600 nm was
obtained at 5 g l1 beef extract among the nine organic
nitrogen sources, while (NH4)2SO4 gave the highest
WAP/OD600 nm at 5 g l
1 among the three inorganic
nitrogen sources (Fig. 4E). Next, we tested a combined
use of beef extract (5 g l1) and (NH4)2SO4 (5 g l
1) as
the organic and inorganic nitrogen sources, respectively,
for WAP-8294A production in strain OH11-MHSAF.
Unexpectedly, the addition of (NH4)2SO4 into the med-
ium containing beef extract seriously inhibited the cell
growth and WAP-8294A production (Fig. S2). WAP-
8294A was barely detectable when the concentration of
(NH4)2SO4 was over 5 g l
1.
Previous studies have shown that soybean oil is an
important component of media for WAP-8294A biosyn-
thesis (Kato et al., 1997; Zhang et al., 2011; Yu et al.,
2018). To optimize the media, we tested the effect of
different concentrations (0–16 g l1) of soybean oil in
the media on WAP-8294A yield and cell growth
(Fig. 4G–I). The results showed that soybean oil gener-
ally exhibited a positive effect on both WAP-8294A yield
and cell growth. The medium containing 16 g l1 soy-
bean oil produced eight- to ninefold more WAP-8294A
than the medium without any soybean oil (Fig. 4G).
However, when soybean oil concentration was over
16 g l1, it became difficult to extract and prepare WAP-
8294A from the viscous fermentation broth. Therefore,
soybean oil at 16 g l1 was chosen in the modified med-
ium (GBS) for WAP-8294A production.
The effect of salts on WAP-8294A production had not
been previously investigated. We tested the effect of cal-
cium salts (CaCO3 and CaCl2) on WAP-8294A produc-
tion and cell growth (Fig. 4J–L). The result showed that
CaCO3 is generally a better calcium source than CaCl2
for WAP-8294A production and cell growth, and the
addition of CaCl2 into the media actually had a harmful
effect. CaCO3 at 1.0 g l
1 achieved the highest WAP-
8294A production and was used in the modified medium
(GBS). Next, we checked the effect of NaCl (Fig. 4M–
O). While it had a clearly positive effect on WAP-8294A
production, NaCl exhibited little effect on cell growth in
the modified medium. Therefore, 1.0 g l1 NaCl was
chosen and used in the modified medium (GBS) for
WAP-8294A production.
Finally, we investigated the effect of initial pH of the
media on WAP-8294A yield and cell growth. While the
cell density was not significantly affected by pH in the
range of 5.5–10.0, the WAP-8294A yield was clearly at
the highest when pH was in the range of 7.5–8.5
(Fig. 4P–R). WAP-8294A yield reached 468.5 lg van-
comycin equivalent per ml when the GBS medium was
at pH 8.5.
WAP-8294A production under the optimal conditions
With the development of GBS medium, we scaled up the
WAP-8294A production and cell growth of
Fig. 3. WAP-8294A yield (A), density of Lysobacter cultures grown at 30°C for 72 h (B) and relative yield of WAP-8294A based on culture den-
sity (C). The data were from three replicates.
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Fig. 4. Effects of medium component and pH on WAP-8294A production, cell density and relative yield of WAP-8294A of L. enzymogenes
OH11-MHSAF. The data were from three replicates.
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L. enzymogenes OH11-MHSAF using a fermenter. In
standard 250-ml flasks, the time-course of WAP-8294A
production was dramatically different in the starting med-
ium (GSS) and the optimized medium (GBS), although
the profile of cell density was similar (Fig. 5). WAP-
8294A yield in GBS was significantly increased, reaching
330.6 lg vancomycin equivalent per ml at 48 h, which
was over 10-fold higher than that in GSS medium. In the
scale-up 14-litre fermenter, the maximum WAP-8294A
yield was achieved by 507.4 lg vancomycin equivalent
per ml in GBS at 36 h (Fig. 6). The result indicates that
the improvement of WAP-8294A yield in GBS medium is
scalable in strain OH11-MHSAF. Interestingly, strain
OH11-MHSAF exhibited diauxic growth in GBS medium
during the 144-h fermentation, and the maximum
OD600 nm reached 20.1 at 96 h. The dissolved oxygen
(DO) of fermentation broth decreased from the initial fer-
mentation until 10th h and then gradually increased and
remained around 70% until the end of fermentation. In
addition, the pH was kept at around 7.0 before 36 h and
afterwards decreased to 4.7 at 96 h and maintained until
the end of fermentation.
Profile change in WAP-8294A congeners in different
conditions
Among the WAP-8294A family, WAP-8294A2 is the pre-
dominant member produced by Lysobacter strains under
standard conditions (Fig. 1) (Kato et al., 1997; Zhang
et al., 2011; Yu et al., 2018). To investigate whether the
optimized conditions in GBS medium would have any
effect on the profile of the WAP-8294A congeners, we
used LC-MS to examine the production of the three main
congeners, WAP-8294A1, WAP-8294A2 and WAP-
8294A4 (Fig. 7). LC-MS data showed that the peak area
of WAP-8294A1, WAP-8294A2 and WAP-8294A4 from
strain OH11-MHSAF in the optimized GBS medium
increased by 8.2-, 4.9- and 6.7-fold, respectively, when
compared to that in the starting GSS medium. Using
standard WAP-8294A2 as a reference, the yield of
WAP-8294A under the optimized conditions was esti-
mated to be approximately 4 mg l1. In addition, the
main WAP-8294A peak was WAP-8294A2 when the
strains grew in GSS medium, which is consistent with
previous reports (Kato et al., 1997; Zhang et al., 2011;
Yu et al., 2018). Interestingly, the main peak became
WAP-8294A1 when the strains were growing in GBS
medium. The change in the WAP-8294A profile in GBS
medium was unexpected but interesting, because this
finding suggests that it may be possible to selectively
enhance a particular congener through further optimizing
the media.
Discussion
In this work, we systematically examined the culture con-
ditions optimal for WAP-8294A production in L. enzymo-
genes OH11. Although the WAP-8294A family had been
isolated more than 20 years ago and one family member
(WAP-8294A2, Lotilibcin) has been in clinical studies for
about 10 years, the development of WAP-8294A into
new therapeutics to fight against multidrug-resistant
MRSA and other superbugs still has not been realized.
One of the roadblocks is related to the supply of the
compounds for both research and development. In this
work, we attempted to address this problem by develop-
ing culture conditions in which WAP-8294A yield is sig-
nificantly improved in L. enzymogenes OH11.
The regulatory mechanisms for WAP-8294A are not
well understood at present. There are numerous factors
that can contribute to the overall yield of the natural
products in L. enzymogenes OH11. To optimize the cul-
ture conditions quickly and effectively, we needed to
develop a simple and easy screening method for antibi-
otic activity in various culture conditions of L. enzymoge-
nes OH11. Using B. subtilis as the testing organism, we
discovered that a reliable co-relation between the size of
inhibition zones and the vancomycin concentration could
be established through serial dilutions of vancomycin
concentrations. With this relationship, we were able to
Fig. 5. Time-courses of cell density (A) and WAP-8294A production (B) by L. enzymogenes OH11-MHSAF in GSS medium (blue curve) versus
GBS medium (red curve) in small cultures (50 ml volume in 250-ml flasks) under the optimized conditions. The data were from three replicates.
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use vancomycin equivalent to semi-quantitatively repre-
sent the antibiotic activity of WAP-8294A in the cultures
of L. enzymogenes OH11. This simple method enabled
us to quickly examine the sources and concentrations of
nutrients, including the carbon source, the nitrogen
source and other supplements such as soybean oil and
salts, as well as other growth conditions. With the opti-
mized culture conditions, we were able to improve the
WAP-8294A yield by 10-fold, reaching 330.6 lg
vancomycin equivalent per ml, in small-scale cultures,
while maintaining a high cell density (Fig. 5). Further-
more, we showed that the optimized culture conditions
could be used in scale-up fermentation, which achieved
507.4 lg vancomycin equivalent per ml in a 14-litre fer-
mentation (Fig. 6).
Additionally, we found an interesting phenomenon
about the profile of the WAP-8294A compounds in the
optimized culture conditions. In all previous studies,
Fig. 6. Time-courses of WAP-8294A production and culture parameters of L. enzymogenes OH11-MHSAF grown in GBS medium in a large-
scale culture (14 L in a fermenter).
Fig. 7. Profiles of the three main congeners of WAP-8294A from L. enzymogenes OH11 and L. enzymogenes OH11-MHSAF grown in GSS
medium versus in GBS medium. The compounds were extracted from the cultures using n-butanol/ethyl acetate (1/1, vol) containing 0.05%
TFA. A. Total ion current of the extract from OH11 grown in GSS; (B) total ion current of the extract from OH11-MHSAF grown in GSS; (C) rela-
tive peak area of WAP-8294A1, A2, A4 in GSS, with WAP-8294A1 peak area setting to 1; (D) total ion current of the extract from OH11 grown
in GBS; (E) total ion current of the extract from OH11-MHSAF grown in GBS; (F) relative peak area of WAP-8294A1, A2, A4 in GBS, with
WAP-8294A1 peak area setting to 1.
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WAP-8294A2 is the predominant congener of the family.
However, WAP-8294A1 becomes the major congener
when the strains of L. enzymogenes OH11 were growing
under the modified conditions. WAP-8294A1 differs from
WAP-8294A2 by one methyl group in the side-chain fatty
acid of the cyclopeptides (Fig. 1). This suggests that the
fatty acid precursor for WAP-8294A1 might be more
abundant in the medium, or more efficiently activated
and incorporated under the conditions, or both. Further
experiments are needed to confirm this idea. Notably,
although WAP-8294A2 is not the predominant congener,
the yield of all three compounds, WAP-8294A1, WAP-
8294A2 and WAP-8294A4, increased by 8.2-, 4.9- and
6.7-fold, respectively, under the conditions. It should also
be pointed out that this estimation was based on LC-MS
analysis, and the peak area-based result is in general
agreement with the activity-based (vancomycin equiva-
lent) results for yield improvement (10- to 15-fold
increase of the overall activity).
In summary, we have developed a practical culture
method for WAP-8294A yield improvement in L. enzy-
mogenes OH11. The method enables to prepare a rela-
tively large quantity of WAP-8294A compounds in a
relatively short time frame. This will greatly facilitate the
ongoing efforts in the basic research and clinical studies
to develop the potent antibiotic compounds into true ther-
apeutics for treatment of infections.
Experimental procedures
Microorganisms and culture conditions
Lysobacter enzymogenes OH11 (CGMCC No. 1978)
(Qian et al., 2009) is the wild-type strain, from which we
previously isolated the WAP-8294A compounds (Zhang
et al., 2011). L. enzymogenes OH11-MHSAF is an engi-
neered strain, in which the key HSAF biosynthetic gene
(hsaf-pks-nrps) has been deleted (Wang et al., 2014).
This strain provides a relatively ‘clean’ background for
metabolite isolation, because HSAF is the major natural
product constitutively produced by OH11 (Yu et al.,
2007). The media used for growth of all strains of L.
enzymogenes OH11 is listed in Table S1.
Extraction and analysis of WAP-8294A compounds from
L. enzymogenes strains
Stock cultures of L. enzymogenes strains OH11 and
OH11-MHSAF were inoculated to LB medium containing
50 lg ml1 kanamycin and allowed to grow at 30°C for
overnight with 200 rpm shaking. A fraction (1%, 0.5 ml)
of the seed culture of each of the strains was inocu-
lated into a 250-ml flask containing 50 ml of one of the
three media, GSS, 1/10 TSB or R2A. The cultures were
incubated at 30°C for 72 h with 200 rpm shaking. The
procedure for extraction and analysis of WAP-8294A
compounds was essentially identical to that reported
previously (Yu et al., 2018). Briefly, the culture broth
was collected and added with 37% HCl to adjust pH to
2.5. A solvent mixture, n-butanol/ethyl acetate (1/1, vol)
containing 0.05% TFA, was added to the broth to
extract the compounds, and the organic phase was col-
lected and dried. Finally, methanol (200 ll containing
0.05% TFA) was used to dissolve the residues that
contained WAP-8294A compounds. For qualitative anal-
ysis, a 20 ll aliquot of each extracts was analysed by
LC-MS as described previously (Yu et al., 2018). For
semi-quantitative analysis, the inhibition zone method
was used (Delgado et al., 2005; Falzone et al., 2017).
Bacillus subtilis was used as the indicator microorgan-
ism for the antibacterial activity of WAP-8294A com-
pounds, and the size of inhibition zones on plates was
used as a measurement of WAP-8294A concentration,
based on a standard curve generated from a serial dilu-
tion of vancomycin as a function of the size of inhibition
zones. Specifically, B. subtilis was incubated in 3 ml LB
medium at 37°C for 6 h with shaking. The culture was
diluted using LB medium to obtain a bacterial solution
with OD600 nm of 0.3. The indicator microorganism solu-
tion was mixed with LB medium (50°C) containing 0.8%
agar at the ratio of 1:1000, and the mixture was poured
into a plate for solidification. Wells of 4 mm diameter
were punched on the plates, and each of the wells was
added with an aliquot (20 ll) of various WAP-8294A
preparations that were serial diluted by ddH2O (twofold
to 128-fold dilutions). Vancomycin was used as a con-
trol in the assays, in which a serial dilution of van-
comycin was added to wells on the plates in parallel to
the WAP-8294A preparations. Finally, the plates were
incubated at 30°C until clear inhibition zones appeared.
The diameter of inhibition zones was measured, and
the experiments were repeated five times until a rela-
tionship between the zone diameters, and vancomycin
concentrations was established, which was used to
derive a standard curve for semi-quantitative estimation
of ‘vancomycin equivalent’ activity in the WAP-8294A
preparations.
Evaluation of the effect of individual nutrients and growth
conditions on WAP-8294A production
Strain L. enzymogenes OH11-MHSAF was selected for
the study, because this strain consistently produced a
higher yield than other strains in the starting GSS med-
ium (Table S1) (Zhang et al., 2011). To evaluate the car-
bon nutrient’s influence on WAP-8294A production, we
tested nine different carbon sources, which were used to
replace glucose (20 g l1) in the starting GSS medium.
A fraction (1%, 0.5 ml) of overnight seed culture of strain
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OH11-MHSAF was inoculated into each of the media
(50-ml in 250-ml flasks) that contained a different carbon
source. The flasks were incubated at 30°C for 72 h with
shaking at 200 rpm. The WAP-8294A compounds were
extracted from the cultures and measured using the
method described above. Similarly, to evaluate the effect
of different nitrogen sources on WAP-8294A production,
soybean flour in the starting GSS medium was replaced
with one of 12 nitrogen sources, at the concentration of
0, 5, 10 and 20 g l1. Meanwhile, glucose (20 g l1)
was used as the carbon source and other nutrients were
not changed.
In addition, the effect of different concentrations of
(NH4)2SO4 on WAP-8294A was assessed. Ammonium
sulphate, at the concentration of 0, 1, 3, 5 and 10 g l1,
was chosen as the inorganic nitrogen source in the
modified GSS medium, in which glucose (20 g l1) was
used as carbon source, beef extract (5 g l1) was used
as organic nitrogen source, and other nutrients were
not changed. Similarly, the effect of different concentra-
tions of soybean oil on WAP-8294A production was
evaluated. Soybean oil at the concentration of 0, 2, 4,
8 and 16 g l1 was tested in the same modified GSS
medium.
To test the effect of salts, WAP-8294A production was
compared in a modified GSS medium containing either
CaCO3 or CaCl2, at the concentration of 0, 1, 3, 5 and
10 g l1. This modified GSS medium contained glucose
(20 g l1), beef extract (5 g l1), soybean oil (16 g l1)
and other nutrients in the original GSS medium. Next,
different concentrations of NaCl, 0, 1, 2, 2.5, 5 and
10 g l1, were tested for their effect on WAP-8294A pro-
duction in a medium containing glucose (20 g l1), beef
extract (5 g l1), soybean oil (16 g l1) and CaCO3
(1 g l1), with no change in other nutrients in the original
GSS medium. From these tests, a new medium, named
GBS (Table S1), was developed for optimal production
of WAB-8294A compounds in strain OH11-MHSAF.
Finally, the effect of initial pH and initial volume of the
culture media was tested. GBS medium with an initial
pH in the range of 5.5-10.0 was prepared, and the WAP-
8294A production was measured in each of the condi-
tions. Based on the outcome of pHs, GBS medium with
an initial pH of 8.5 was selected for WAP-8294A produc-
tion in an initial medium volume varying from 20 to
100 ml in 250-ml flasks.
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Fig. S1. Time courses of WAP-8294A production (A) and
cell density (B) of two strains of Lysobacter grown in GSS
medium at 30°C, and the anti-Bacillus activity of the strains
grown in GSS medium at 30°C for 72 h (C). The data were
from three replicates.
Fig. S2. Effect of (NH4)2SO4 on the WAP-8294A production
(A), cell density (B), and relative yield of WAP-8294A (C) of
L. enzymogenes OH11-MHSAF, using 5 g l1 beef extract
as the organic nitrogen source. The data were from three
replicates.
Table S1. Composition of culture media using in this study.
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